Alvin P. Makohon-Moore
Alvin P. Makohon-Moore
Research Associate, Memorial Sloan Kettering
E-mail megerősítve itt:
Hivatkozott rá
Hivatkozott rá
Pancreatic cancer biology and genetics from an evolutionary perspective
A Makohon-Moore, CA Iacobuzio-Donahue
Nature reviews Cancer 16 (9), 553-565, 2016
Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis
OG McDonald, X Li, T Saunders, R Tryggvadottir, SJ Mentch, ...
Nature genetics 49 (3), 367-376, 2017
Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer
AP Makohon-Moore, M Zhang, JG Reiter, I Bozic, B Allen, D Kundu, ...
Nature genetics 49 (3), 358-366, 2017
Whole genome sequencing defines the genetic heterogeneity of familial pancreatic cancer
NJ Roberts, AL Norris, GM Petersen, ML Bondy, R Brand, S Gallinger, ...
Cancer discovery 6 (2), 166-175, 2016
Minimal functional driver gene heterogeneity among untreated metastases
JG Reiter, AP Makohon-Moore, JM Gerold, A Heyde, MA Attiyeh, ...
Science 361 (6406), 1033-1037, 2018
Retrotransposon insertions in the clonal evolution of pancreatic ductal adenocarcinoma
N Rodić, JP Steranka, A Makohon-Moore, A Moyer, P Shen, R Sharma, ...
Nature medicine 21 (9), 1060-1064, 2015
Widespread somatic L1 retrotransposition occurs early during gastrointestinal cancer evolution
AD Ewing, A Gacita, LD Wood, F Ma, D Xing, MS Kim, SS Manda, G Abril, ...
Genome research 25 (10), 1536-1545, 2015
Reconstructing metastatic seeding patterns of human cancers
JG Reiter, AP Makohon-Moore, JM Gerold, I Bozic, K Chatterjee, ...
Nature communications 8 (1), 1-10, 2017
An analysis of genetic heterogeneity in untreated cancers
JG Reiter, M Baretti, JM Gerold, AP Makohon-Moore, A Daud, ...
Nature Reviews Cancer 19 (11), 639-650, 2019
Precancerous neoplastic cells can move through the pancreatic ductal system
AP Makohon-Moore, K Matsukuma, M Zhang, JG Reiter, JM Gerold, ...
Nature 561 (7722), 201-205, 2018
Transcriptional mechanisms of resistance to anti–PD-1 therapy
ML Ascierto, A Makohon-Moore, EJ Lipson, JM Taube, TL McMiller, ...
Clinical Cancer Research 23 (12), 3168-3180, 2017
Pancreatic cancer genomics: insights and opportunities for clinical translation
A Makohon-Moore, JA Brosnan, CA Iacobuzio-Donahue
Genome medicine 5 (3), 1-11, 2013
A unifying paradigm for transcriptional heterogeneity and squamous features in pancreatic ductal adenocarcinoma
A Hayashi, J Fan, R Chen, Y Ho, AP Makohon-Moore, N Lecomte, ...
Nature Cancer 1 (1), 59-74, 2020
Prevalence of filarioid nematodes and trypanosomes in American robins and house sparrows, Chicago USA
GL Hamer, TK Anderson, GE Berry, AP Makohon-Moore, JC Crafton, ...
International Journal for Parasitology: Parasites and Wildlife 2, 42-49, 2013
Mutant p53 together with TGFβ signaling influence organ-specific hematogenous colonization patterns of pancreatic cancer
Y Zhong, A Macgregor-Das, T Saunders, MC Whittle, A Makohon-Moore, ...
Clinical Cancer Research 23 (6), 1607-1620, 2017
The evolutionary origins of recurrent pancreatic cancer
H Sakamoto, MA Attiyeh, JM Gerold, AP Makohon-Moore, A Hayashi, ...
Cancer Discovery 10 (6), 792-805, 2020
Accelerated single cell seeding in relapsed multiple myeloma
HJ Landau, V Yellapantula, BT Diamond, EH Rustad, KH Maclachlan, ...
Nature communications 11 (1), 1-10, 2020
Characterization of genetic subclonal evolution in pancreatic cancer mouse models
N Niknafs, Y Zhong, JA Moral, L Zhang, MX Shao, A Lo, ...
Nature communications 10 (1), 1-10, 2019
Local recurrences at the anastomotic area are clonally related to the primary tumor in sporadic colorectal carcinoma
E Vakiani, RH Shah, MF Berger, AP Makohon-Moore, JG Reiter, ...
Oncotarget 8 (26), 42487, 2017
Tumor diversity and evolution revealed through RADseq
EB Perry, A Makohon-Moore, C Zheng, CK Kaufman, J Cai, ...
Oncotarget 8 (26), 41792, 2017
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20